Sabra director granted 781 stock units in award

Catherine Cusack, a director of Sabra Health Care REIT, Inc., reported an acquisition of 781 shares of common stock on the basis of dividend equivalent payments on previously granted stock units.

Rhea-AI Filing Summary

Catherine Cusack, a director of Sabra Health Care REIT, Inc., reported an acquisition of 781 shares of common stock on the basis of dividend equivalent payments on previously granted stock units. The award was priced at $0.00 per share, reflecting a stock unit credit rather than a cash purchase.

After this transaction, Cusack’s direct holdings increased to 72,929 stock units and shares, including 2,854 unvested stock units and 51,345 vested stock units with deferred payment. Each stock unit represents the right to receive one share of Sabra’s common stock under the company’s 2009 Performance Incentive Plan.

Insider Trade Summary

Grant/Award: 781 shares

Grant/Award 1 txn

Insider Cusack Catherine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	781	$0.00	$0.00

Holdings After Transaction: Common Stock — 72,929 shares (Direct)

Footnotes (2)

1. F1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
2. F2. Includes 2,854 unvested stock units and 51,345 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sabra Health Care REIT (SBRA) report for Catherine Cusack?

Sabra Health Care REIT director Catherine Cusack reported receiving 781 stock units as dividend equivalent payments on previously granted units. These credits are non-cash awards under the company’s 2009 Performance Incentive Plan and increase her overall equity-based holdings in the REIT.

How many Sabra Health Care REIT (SBRA) shares or units does Catherine Cusack hold after this Form 4?

Following the February transaction, Catherine Cusack directly holds 72,929 stock units and shares in Sabra Health Care REIT. This includes 2,854 unvested units and 51,345 vested units whose payment has been deferred, each representing one share of common stock.

Was Catherine Cusack’s Sabra Health Care REIT (SBRA) Form 4 transaction a stock purchase or a grant?

The Form 4 reflects a grant/award acquisition, not an open-market stock purchase. Cusack received 781 stock units at $0.00 per share as dividend equivalent credits on outstanding stock units under Sabra’s 2009 Performance Incentive Plan.

What are dividend equivalent stock units in the Sabra Health Care REIT (SBRA) Form 4?

Dividend equivalent stock units are additional units credited based on dividends paid on existing awards. For Cusack, 781 units were calculated using the market value of Sabra’s common stock on the dividend payment date and will vest on the same terms as the original units.

When will the new Sabra Health Care REIT (SBRA) stock units granted to Catherine Cusack vest and be payable?

The 781 new stock units granted to Catherine Cusack will vest and become payable on the same schedule as the original stock units they relate to. The Form 4 notes they follow the existing vesting and payment terms set under the 2009 Performance Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 02:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cusack Catherine

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CA 92782

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		781(1)	A	$0	72,929(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

2. Includes 2,854 unvested stock units and 51,345 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.